The results of this study demonstrate both the comprehensive electrical evaluation of the heart and repeatability of the electrophysiology testing protocol for arrhythmia generation and for safety evaluation of new chemical and biological entities.
About the Presenter
Brian Roche
Exec Director Global Safety Pharmacology